BR112014031302A2 - produto nutricional - Google Patents

produto nutricional

Info

Publication number
BR112014031302A2
BR112014031302A2 BR112014031302A BR112014031302A BR112014031302A2 BR 112014031302 A2 BR112014031302 A2 BR 112014031302A2 BR 112014031302 A BR112014031302 A BR 112014031302A BR 112014031302 A BR112014031302 A BR 112014031302A BR 112014031302 A2 BR112014031302 A2 BR 112014031302A2
Authority
BR
Brazil
Prior art keywords
nutritional product
invention generally
generally relates
field
disorders associated
Prior art date
Application number
BR112014031302A
Other languages
English (en)
Inventor
Lambert Bridget
Cross Helen
O'donnell Maura
Rutherford Patricia
Wallis Patricia
Hughes Sean-David
Eaton Simon
Heales Simon
Original Assignee
Ucl Business Plc
Vitaflo Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46641031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014031302(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucl Business Plc, Vitaflo Int Ltd filed Critical Ucl Business Plc
Publication of BR112014031302A2 publication Critical patent/BR112014031302A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

resumo patente de invenção: "produto nutricional". a presente invenção refere-se geralmente ao campo das terapias dietéticas para tratar desordens associadas com a disfunção mitocondrial, incluindo epilepsia.
BR112014031302A 2012-06-15 2013-06-14 produto nutricional BR112014031302A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1210699.3A GB201210699D0 (en) 2012-06-15 2012-06-15 Nutritional food
US201261704277P 2012-09-21 2012-09-21
PCT/GB2013/051561 WO2013186570A1 (en) 2012-06-15 2013-06-14 Nutritional product

Publications (1)

Publication Number Publication Date
BR112014031302A2 true BR112014031302A2 (pt) 2017-06-27

Family

ID=46641031

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014031302A BR112014031302A2 (pt) 2012-06-15 2013-06-14 produto nutricional

Country Status (13)

Country Link
US (2) US11344522B2 (pt)
EP (2) EP4162934A1 (pt)
JP (4) JP2015522256A (pt)
CN (2) CN107456450A (pt)
AU (5) AU2013276254A1 (pt)
BR (1) BR112014031302A2 (pt)
CA (1) CA2876286C (pt)
DK (1) DK2861226T3 (pt)
ES (1) ES2933408T3 (pt)
FI (1) FI2861226T3 (pt)
GB (1) GB201210699D0 (pt)
HK (1) HK1208367A1 (pt)
WO (1) WO2013186570A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201210699D0 (en) 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
CN105377252A (zh) 2013-03-14 2016-03-02 佛罗里达大学研究基金会 利用天然化合物和/或饮食调控癌症
WO2015127320A2 (en) * 2014-02-20 2015-08-27 Iycus, Llc Single serve beverage compositions
CN106659220A (zh) * 2014-07-17 2017-05-10 日清奥利友集团株式会社 营养组合物
JP5881784B2 (ja) * 2014-07-17 2016-03-09 日清オイリオグループ株式会社 ゲル状乳化食品
US20170202239A1 (en) * 2014-07-17 2017-07-20 The Nisshin Oillio Group, Ltd. Baked confectionery that substantially includes no flour
WO2016131640A1 (en) * 2015-02-20 2016-08-25 Nestec S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US11020372B2 (en) 2015-03-24 2021-06-01 University Of Florida Research Foundation, Incorporated Dietary and natural product management of negative side effects of cancer treatment
EP3313395A4 (en) * 2015-06-26 2019-02-06 University of Florida Research Foundation, Inc. METHOD FOR THE TREATMENT OF INFLAMMATION THROUGH NATURAL CONNECTIONS AND / OR NUTRITION
CN108348496A (zh) * 2015-12-04 2018-07-31 雀巢产品技术援助有限公司 中链三甘油酯组合物
US11826331B2 (en) 2016-10-31 2023-11-28 The Cleveland Clinic Foundation Capric acid and myristic acid compositions for treating conditions
WO2018138620A1 (en) * 2017-01-29 2018-08-02 Gupta Samit Ketogenic nutritional composition and preparation method thereof
EP3609489A1 (en) 2017-04-10 2020-02-19 Vitaflo International Ltd. Composition for use in the treatment of epilepsy
MX2019014313A (es) * 2017-06-29 2022-08-04 Vitaflo Int Ltd Combinacion que comprende acido decanoico para el tratamiento de la epilepsia.
CN112513260A (zh) * 2018-01-23 2021-03-16 通用医疗公司 用于改善线粒体功能的组合物和方法
KR102199688B1 (ko) 2018-11-20 2021-01-07 (주)엠디웰아이엔씨 수술 후 환자 영양불량 예방 또는 영양상태 회복 촉진용 식품 조성물
CN112006273B (zh) * 2020-06-05 2023-10-03 成都天一美膳营养食品有限公司 一种不生酮的健康减脂代餐粉及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003425A1 (fr) 1968-03-07 1969-11-07 Unilever Nv Compositions grasses plastiques comestibles et procede pour les preparer
NZ513329A (en) 1999-02-05 2003-11-28 Baylor University Medical Ct Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US20080009467A1 (en) * 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
DK1292294T3 (da) 2000-05-01 2009-06-22 Accera Inc Anvendelse af mediumkæde-triglycerider til behandling og forebyggelse af Alzheimers sygdom
EP1915144A4 (en) 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
JP5447954B2 (ja) * 2007-09-19 2014-03-19 公益財団法人名古屋産業科学研究所 神経栄養因子様作用剤
EP2249823A4 (en) 2008-02-15 2011-05-18 Us Gov Health & Human Serv OCTANOIC ACID FORMULATION AND METHODS OF TREATMENT EMPLOYING THE SAME
JP5059947B2 (ja) 2008-11-06 2012-10-31 日清オイリオグループ株式会社 濃厚流動食
WO2011040342A1 (ja) * 2009-09-30 2011-04-07 日清オイリオグループ株式会社 パーキンソン病患者の内臓脂肪減少抑制剤
JP5749915B2 (ja) * 2010-11-02 2015-07-15 花王株式会社 オートインデューサー−２阻害剤
GB201020133D0 (en) 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
GB201210699D0 (en) 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
JP5764270B1 (ja) 2013-11-15 2015-08-19 日清オイリオグループ株式会社 改良豆乳及びその製造方法
CN106659220A (zh) 2014-07-17 2017-05-10 日清奥利友集团株式会社 营养组合物

Also Published As

Publication number Publication date
US11344522B2 (en) 2022-05-31
ES2933408T3 (es) 2023-02-08
EP2861226A1 (en) 2015-04-22
AU2022253500A1 (en) 2022-11-17
JP2021107394A (ja) 2021-07-29
FI2861226T3 (fi) 2023-01-31
AU2019226282A1 (en) 2019-09-26
JP2023100665A (ja) 2023-07-19
JP2015522256A (ja) 2015-08-06
AU2021202459A1 (en) 2021-05-20
CN104519880A (zh) 2015-04-15
DK2861226T3 (da) 2023-01-30
AU2021202459B2 (en) 2022-07-21
CN107456450A (zh) 2017-12-12
JP2018121635A (ja) 2018-08-09
US20150164840A1 (en) 2015-06-18
AU2013276254A1 (en) 2014-12-18
CA2876286A1 (en) 2013-12-19
EP4162934A1 (en) 2023-04-12
EP2861226B1 (en) 2022-11-02
CA2876286C (en) 2021-03-16
US20220273602A1 (en) 2022-09-01
AU2018200433A1 (en) 2018-02-08
GB201210699D0 (en) 2012-08-01
HK1208367A1 (en) 2016-03-04
WO2013186570A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
BR112014031302A2 (pt) produto nutricional
BR112016009889A2 (pt) ?compostos agonistas duplos gip-glp-1 e métodos?
WO2012106407A3 (en) Diagnostic and therapeutic methods and products related to anxiety disorders
MD20170020A2 (ro) Compoziţii şi metode utilizate pentru tratamentul tulburărilor metabolice
WO2012114204A3 (en) Methods of treating mitochondrial dysfunction
MX2015006234A (es) Uso de akkermansia para tratar trastornos metabolicos.
WO2012125408A8 (en) Pegylated apelin and uses thereof
BR112013022052A2 (pt) ligantes antagonísticos de dr3
MX2017004658A (es) Sulfatos de colesterol oxigenado para terapia contra trastornos provocados por al menos uno de actividad atenuada de leptina y un trastorno de almacenamiento lipidico.
EP3324964A4 (en) AMPHIPHILE PYRIDINIUM COMPOUNDS FOR THE TREATMENT OF EPILEPSIA AND OTHER DISEASES OF THE NERVOUS SYSTEM
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
WO2017106367A8 (en) Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
EP3071543A4 (en) Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complement-mediated disorders
MX2015007862A (es) Derivado de amida del acido cinamico.
AU2019268209A1 (en) Compounds for the treatment of seizures and other central nervous system disorders and conditions
WO2012123561A3 (de) Agens zur prophylaxe und behandlung altersassoziierter krankheiten und störungen sowie zur verlängerung der lebensdauer
EA201491291A1 (ru) АГОНИСТЫ mGlu 2/3
BR112013006307A2 (pt) fenilacetamidas e fenilpropanamidas substituídas e o seu uso
CR20120445A (es) Ariltriazolonas ligadas a bisarilo y su uso
TH46813S1 (th) ชิ้นส่วนเข็มเจาะสำหรับให้สารละลาย
TH131908S (th) ชิ้นส่วนเข็มเจาะสำหรับให้สารละลาย
TH155501S (th) เก้าอี้
AU2013100891A4 (en) JHF Cream No.1 used to treat inflammatory skin diseases
TH124620B (th) อุปกรณ์ยึด
TH124621B (th) อุปกรณ์ยึด

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]